Nitric oxide enhancement of melphalan-induced cytotoxicity
1997

Nitric Oxide Enhances Melphalan's Cancer-Killing Effects

publication Evidence: moderate

Author Information

Author(s): JA Cook, MC Krishna, R Pacelli, W DeGraff, J Liebmann, JB Mitchell, A Russo, DA Wink

Primary Institution: National Cancer Institute

Hypothesis

Does nitric oxide enhance the cytotoxicity of melphalan in cancer cells?

Conclusion

Nitric oxide significantly enhances the cytotoxicity of melphalan in both V79 and MCF-7 cancer cells.

Supporting Evidence

  • NO treatment resulted in a 50% reduction in survival for V79 cells.
  • Melphalan cytotoxicity was enhanced by approximately 3.6-fold in V79 cells and 4.3-fold in MCF-7 cells with NO treatment.
  • NO pretreatment resulted in a delayed entry into S phase and a G/M block for both V79 and MCF-7 cells.
  • Melphalan uptake was increased by 33% after NO exposure in V79 cells.

Takeaway

Nitric oxide helps make a cancer drug called melphalan work better at killing cancer cells.

Methodology

Clonogenic assays were used to assess the effects of nitric oxide on melphalan-induced cytotoxicity in V79 and MCF-7 cells.

Limitations

The study primarily focused on two cell lines, which may limit the generalizability of the findings.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication